DTC (Direct to Consumer) DNA Test Kits Market Overview
The DTC (direct to consumer) DNA test kits market is estimated to reach at a high CAGR during the forecast period 2024-2031
DTC (Direct to Consumer) DNA test is being used to diagnose genetic disease, forensic sciences, etc. DNA tests can be used to determine paternity and study ancestry or familial origin.
Market Scope
| Metrics | Details |
| Market CAGR | High |
| Segments Covered | By Sample Type, By Application, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Know More Insights - Download Sample
Market Dynamics
The global DTC (direct to consumer) DNA test kits market growth is driven by the increasing demand for paternity testing, rising prevalence of hereditary diseases, and rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits.
Growing awareness among general people about the availability of direct-to-consumer genetic tests is expected to drive growth in the forecast period
Growing awareness among general people about the availability of direct-to-consumer genetic tests in developed and developing nations will fuel the market growth over the projected timeline. Notable industry participants have channelled their focus on developing superior quality direct-to-consumer genetic testing solutions. These tests assure to provide effective and accurate genetic test outcomes. This drives the global Direct-To-Consumer (DTC) DNA Test kits Market. Moreover, companies such as 23andMe have taken special marketing efforts to promote their direct-to-consumer genetic tests via retail pharmacies and online channels. The companies also market their commodities with promotional offers and pleasant discounts.
Furthermore, the growing number of laboratories researching DNA kits for gynecological purposes is also a major factor that drives the market growth. For instance, the National Congenital Anomaly and Rare Disease Registration Service have stated that around 3 to 6% of babies worldwide are born with a congenital anomaly every year. This increases the need for prenatal testing for anomalies. In addition, the market is largely penetrating towards new research fields of medicine and healthcare; as such, the innovation of probes for preimplantation, prenatal, and postnatal genetic testing research drives the overall market growth.
Certain barriers and hindrances of DTC DNA testing is likely to hamper the market growth
DTC DNA testing raises many scientific, technical, and clinical issues, along with First Amendment issues of honesty, fidelity to facts, and truth-in-advertising. These are the potential restraints hampering the overall growth of the global Direct-To-Consumer (DTC) DNA test kits market. In addition, the difficulty in understanding the kits' results and very little information about the companies selling the kits are restraining the market's growth.
COVID-19 Impact Analysis
Companies in the DNA test kits market are taking cues from Singapore-based MedTech company Cell ID Pte. Ltd. to innovate a portable genetic test for COVID-19. This has helped fuel innovations in mobile apps, which help run tests on-demand, eliminating the waiting time associated with batch processing. Companies in the DNA test kits market are increasing the availability of products, which require lesser training times. Portable COVID-19 genetic tests are replacing conventional PCR tests that take extended hours for positive results to appear.
Market Segment Analysis
The ancestry testing segment is expected to hold the largest share in this market segment
An ancestry test is a DTC DNA-based test that reads specific locations of a subject’s genome to find or validate ancestral hereditary relationships or to evaluate the ethnic combination of an individual. The increasing number of people interested in knowing their ancestors and family trees increases the demand for DTC DNA test kits, especially in developing countries.
An increasing number of companies, such as 23andMe, offer various DNA kits that are helpful in ancestry testing. Developed countries are also witnessing the high demand for such products as awareness about such technologies is higher.
Market Geographical Share
North America region holds the largest market share of the global DTC (direct to consumer) DNA test kits market
North America is expected to dominate the overall DTC DNA test kits market throughout the forecast period. The growth is due to the growing prevalence of congenital anomalies and increasing government initiatives for genetic diagnosis. For instance, according to the All-India Institute of Medical Sciences, the global incidence of congenital adrenal hyperplasia in newborns is roughly 1 in 16,000 to 1 in 20,000. The incidence in the U.S. is around 1 in 16,000 to 1 in 18,000 population. In the North American region, the United States holds the largest market share due to high disposable income, and easy acceptance of such kits in the country is expected to increase the demand in this region.
Companies and Competitive Landscape
The global DTC (direct to consumer) DNA test kits market is highly competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Ancestry.com LLC, 23andMe, MyHeritage Ltd, Gene by Gene, Living DNA Ltd., Helix OpCo, LLC., Veritas Genetics, Futura Genetics, Mapmygenome and Illumina, Inc. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, In July 2018, GlaxoSmithKline partnered with 23andme (GSK). This relationship allowed the company to discover therapies to cure genetic illnesses, which subsequently increased the company’s portion of the direct-to-consumer (DTC) genetic testing market.
Global DTC (Direct to Consumer) DNA Test Kits Market – Market Key Companies to Watch
23andMe
Overview: 23andMe, Inc. is a publicly held personal genomics and biotechnology company based in Sunnyvale, California. Founded in 2006, it is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics.
Product Portfolio: AncestryDNA test is a cutting-edge DNA testing service that utilizes some of the latest autosomal testing technology.
Key Developments: On January 22, 2019, 23andMe receives FDA clearance for a direct-to-consumer genetic test on a hereditary colorectal cancer syndrome.
